Z
Zhejiang Dayang Biotech Group Co Ltd
SZSE:003017
Zhejiang Dayang Biotech Group Co Ltd
SZSE:003017
Price:
31.35
CNY
1.59%
Market Closed
Market Cap:
¥2.6B
Add Note
Add Target
Capture your thoughts and set a target
Decide at what price you'd be comfortable buying and we'll help you stay ready.
Based on
Margin of Safety
0%
10%
20%
30%
40%
50%
Your Price Target
Linked to
current price
· In Buy Zone
Loading
Note attached
Choose the stock you wish to monitor with a price target
Recently Viewed
|
Z
|
Zhejiang Dayang Biotech Group Co Ltd
SZSE:003017
|
CN |
|
Neste Oyj
OMXH:NESTE
|
FI |
|
Jiangsu Yinhe Electronics Co Ltd
SZSE:002519
|
CN |
Income Statement
Earnings Waterfall
Zhejiang Dayang Biotech Group Co Ltd
Zhejiang Dayang Biotech Group Co Ltd
Income Statement
Zhejiang Dayang Biotech Group Co Ltd
Zhejiang Dayang Biotech Group Co Ltd
Currency: CNY
| Dec-2020 | Mar-2021 | Jun-2021 | Sep-2021 | Dec-2021 | Mar-2022 | Jun-2022 | Sep-2022 | Dec-2022 | Mar-2023 | Jun-2023 | Sep-2023 | Dec-2023 | Mar-2024 | Sep-2024 | Dec-2024 | Mar-2025 | Jun-2025 | Sep-2025 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | ||||||||||||||||||||
| Interest Expense |
1
|
1
|
2
|
3
|
4
|
4
|
5
|
5
|
5
|
5
|
5
|
4
|
6
|
6
|
5
|
7
|
4
|
0
|
0
|
|
| Revenue |
678
N/A
|
719
+6%
|
742
+3%
|
750
+1%
|
783
+4%
|
801
+2%
|
890
+11%
|
951
+7%
|
1 058
+11%
|
1 115
+5%
|
1 047
-6%
|
1 038
-1%
|
919
-11%
|
863
-6%
|
634
-27%
|
910
+43%
|
722
-21%
|
972
+35%
|
985
+1%
|
|
| Gross Profit | ||||||||||||||||||||
| Cost of Revenue |
(513)
|
(555)
|
(589)
|
(609)
|
(633)
|
(668)
|
(753)
|
(823)
|
(912)
|
(956)
|
(905)
|
(886)
|
(756)
|
(712)
|
(509)
|
(734)
|
(575)
|
(765)
|
(768)
|
|
| Gross Profit |
166
N/A
|
164
-1%
|
153
-7%
|
142
-7%
|
150
+6%
|
133
-12%
|
137
+3%
|
128
-7%
|
146
+15%
|
160
+9%
|
142
-11%
|
152
+7%
|
163
+8%
|
151
-7%
|
125
-18%
|
176
+41%
|
146
-17%
|
207
+42%
|
217
+5%
|
|
| Operating Income | ||||||||||||||||||||
| Operating Expenses |
(63)
|
(58)
|
(55)
|
(55)
|
(79)
|
(79)
|
(90)
|
(85)
|
(92)
|
(92)
|
(97)
|
(104)
|
(103)
|
(103)
|
(65)
|
(99)
|
(66)
|
(104)
|
(114)
|
|
| Selling, General & Administrative |
(56)
|
(58)
|
(54)
|
(51)
|
(60)
|
(64)
|
(67)
|
(67)
|
(68)
|
(71)
|
(78)
|
(83)
|
(72)
|
(77)
|
(52)
|
(76)
|
(64)
|
(86)
|
(89)
|
|
| Research & Development |
(21)
|
(22)
|
(22)
|
(25)
|
(26)
|
(30)
|
(39)
|
(36)
|
(32)
|
(36)
|
(33)
|
(39)
|
(35)
|
(37)
|
(20)
|
(27)
|
(22)
|
(30)
|
(35)
|
|
| Depreciation & Amortization |
(6)
|
0
|
0
|
0
|
(10)
|
0
|
0
|
0
|
(10)
|
0
|
0
|
0
|
(15)
|
0
|
0
|
(15)
|
0
|
0
|
0
|
|
| Other Operating Expenses |
19
|
22
|
21
|
21
|
18
|
15
|
16
|
18
|
19
|
16
|
14
|
17
|
19
|
12
|
7
|
18
|
19
|
11
|
10
|
|
| Operating Income |
103
N/A
|
106
+3%
|
98
-7%
|
87
-12%
|
72
-17%
|
53
-26%
|
47
-11%
|
43
-10%
|
54
+28%
|
68
+25%
|
46
-33%
|
47
+4%
|
61
+28%
|
49
-20%
|
59
+22%
|
76
+28%
|
80
+5%
|
104
+30%
|
103
0%
|
|
| Pre-Tax Income | ||||||||||||||||||||
| Interest Income Expense |
(1)
|
1
|
4
|
7
|
8
|
6
|
3
|
1
|
1
|
0
|
2
|
4
|
4
|
4
|
(0)
|
4
|
4
|
4
|
7
|
|
| Non-Reccuring Items |
(2)
|
0
|
0
|
0
|
(2)
|
0
|
0
|
0
|
3
|
3
|
3
|
3
|
(17)
|
(0)
|
0
|
(8)
|
0
|
0
|
0
|
|
| Total Other Income |
0
|
(1)
|
(1)
|
(2)
|
(1)
|
(3)
|
(3)
|
(3)
|
(2)
|
(2)
|
(2)
|
(2)
|
(1)
|
(9)
|
(8)
|
(1)
|
(6)
|
(6)
|
(5)
|
|
| Pre-Tax Income |
100
N/A
|
106
+5%
|
102
-4%
|
92
-10%
|
76
-17%
|
56
-26%
|
47
-17%
|
41
-12%
|
57
+40%
|
70
+21%
|
49
-30%
|
52
+7%
|
47
-10%
|
43
-8%
|
51
+17%
|
72
+42%
|
78
+9%
|
102
+30%
|
105
+3%
|
|
| Net Income | ||||||||||||||||||||
| Tax Provision |
(9)
|
(10)
|
(9)
|
(8)
|
(6)
|
(3)
|
8
|
9
|
23
|
22
|
18
|
18
|
3
|
4
|
(4)
|
(8)
|
(11)
|
(14)
|
(7)
|
|
| Income from Continuing Operations |
92
|
96
|
92
|
83
|
70
|
53
|
55
|
51
|
81
|
92
|
67
|
71
|
50
|
48
|
47
|
64
|
67
|
88
|
97
|
|
| Income to Minority Interest |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Net Income (Common) |
92
N/A
|
96
+5%
|
92
-4%
|
83
-10%
|
70
-16%
|
53
-24%
|
55
+3%
|
51
-8%
|
81
+59%
|
92
+14%
|
67
-27%
|
71
+5%
|
50
-29%
|
48
-5%
|
47
-2%
|
64
+37%
|
67
+5%
|
88
+32%
|
98
+11%
|
|
| EPS (Diluted) |
1.53
N/A
|
1.59
+4%
|
1.54
-3%
|
1.39
-10%
|
0.84
-40%
|
0.89
+6%
|
0.93
+4%
|
0.86
-8%
|
0.99
+15%
|
1.14
+15%
|
0.83
-27%
|
0.88
+6%
|
0.62
-30%
|
0.59
-5%
|
0.56
-5%
|
0.78
+39%
|
0.84
+8%
|
1.1
+31%
|
1.2
+9%
|
|
Switch to:
Switch to:
See Also
Discover More
